Late-breaking clinical trial
Home >Results Of Submissions >Late-breaking clinical trial
 

General Information

CIT Late-Breaking Clinical Trials are first-time worldwide presentations of the primary endpoint or important secondary endpoint results of prospective, randomized clinical trials, or the first worldwide presentations of large-scale, impactful single-center or multi-center registries, or first-in-man experiences with novel devices or drugs. Studies accepted as Late-Breaking Clinical Trials will be presented in the Main Arena at CIT 2010 on Thursday, April 1, 2010. An application must be submitted for each Late-Breaking Clinical Trials that you are proposing. By submitting an application, you are warranting that the trial or study is likely to be completed and will be presented at CIT if accepted, whether the results are positive or negative. Presentations of accepted Late-Breaking Clinical Trials prior to CIT are strictly embargoed.


Note: Accepted Late-Breaking Clinical Trials may not be withdrawn for negative results. Such action will negatively impact future applications from both the applicant and the trial sponsor.

Please download the Application Form from the CIT website (www.citmd.com/CIT/2010/down/Late-breaking clinical trial.doc), complete it and send to Mr. Bo Xu, Secretary General of CIT at either bxu@citmd.com or xubofw@263.net before December 31, 2009

Submission deadline:
December 31, 2009

 
 
 
 


 
Copyright©2000-2010 China Interventional Therapeutics (CIT) All Rights Reserved
Email:cit2010@citmd.com